L'intérêt à découvert pour UnitedHealth Group donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de UnitedHealth Group. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

UnitedHealth Group (NYSE:UNH) Stock, Rapport sur les intérêts à découvert

UNITEDHEALTH GROUP INC

UnitedHealth Group

UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

UnitedHealth Group Incorporated Common Stock (DE)

UnitedHealth Group Inc

EC Healthcare

United Hampshire US REIT

Jim Cramer weighed in on the deepening crisis at one of America&#8217;s largest health insurers, which has lately found itself under intense scrutiny by the public, regulators, and the media. 
What Happened: On Thursday, Cramer commented on UnitedHealth Group Inc.'s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) mounting troubles, zeroing in on the company&#8217;s public denial of a Wall Street Journal report about a federal criminal probe, on his X account.
&#8220;UnitedHealth is denying the WSJ story about them,&#8221; Cramer posted, before calling it &#8220;crucial,&#8221; and adding that &#8220;if convicted of criminal Medicare fraud, well, I don&#8217;t know…&#8221; regarding the stock. The CNBC host&#8217;s remarks reflect the uncertainty now gripping the markets and investors as scrutiny over UnitedHealth intensifies.
See More: <a href="https://www.benzinga.com/markets/options/25/05/45460072/wall-street-getting-nervous-magnificent-7-giants-face-33m-bet-against-them-as-market-turbulence-looms">Wall Street Getting Nervous? Magnificent 7 Giants Face $33M Bet Against Them As Market Turbulence Looms</a>
According <a href="https://www.wsj.com/us-news/unitedhealth-medicare-fraud-investigation-df80667f">to</a> the WSJ report, the Justice Department's criminal healthcare fraud division has been investigating UnitedHealth since at least last summer. The probe reportedly centers on billing practices tied to its Medicare Advantage program.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">United Health is denying the WSJ story about them. Crucial because if convicted of criminal Medicare fraud, well, i don&#39;t know&#8230;
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1923018153350631806?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Besides this, the company is facing a barrage of issues, with several other lawsuits from customers, investors, and regulators, the <a href="https://benzinga.com/content/45375716/stat-unitedhealth-stock-tumbles-as-ceo-resigns-2025-outlook-pulled">abrupt exit of its CEO</a> early this week, and a stock that has lost nearly half its value since April.
Why It Matters: The company <a href="https://www.benzinga.com/general/health-care/25/05/45426769/unitedhealth-stock-plunges-over-8-in-after-hours-trading-as-doj-criminal-probe-adds-to-turmoil-after-ceo-shake-up">pushed back against</a> the report when Benzinga reached out to them on Thursday. Saying that they have &#8220;not been notified of any criminal investigation,&#8221; and that they stand by &#8220;the integrity of our Medicare Advantage business,&#8221; while calling WSJ&#8217;s reporting as &#8220;deeply irresponsible.&#8221;
UnitedHealth Group has faced a string of negative catalysts over the past couple of months, starting with <a href="https://www.benzinga.com/general/health-care/24/12/42316904/unitedhealthcare-ceo-brian-thompson-fatally-shot-outside-nyc-hotel">the assassination</a> of its subsidiary, UnitedHealthcare&#8217;s CEO, Brian Thompson, in December 2024. Since then, the company has faced lawsuits from investors, who claim the company hid the potential impact of this assassination.
Early this month, Cramer <a href="https://benzinga.com/trading-ideas/long-ideas/25/05/45133450/jim-cramer-this-consumer-cyclical-stock-is-a-one-trick-pony">changed his stance</a> on the stock, saying that he would &#8220;indeed start a position&#8221; in the stock at $400 a share after being &#8220;very negative&#8221; on it. The stock has since dropped 31% in the preceding two weeks.
Price Action: Shares of UnitedHealth were down 10.93% on Thursday, despite the company dismissing claims of a federal criminal investigation. It is up 1.29% after hours.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="141" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-1024x141.png" alt="" class="wp-image-917435" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-1024x141.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-300x41.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-768x106.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM-1536x212.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16013044/Screenshot-2025-05-16-at-11.00.35-AM.png 1594w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The stock fares poorly across most metrics in Benzinga&#8217;s Edge Stock Rankings. It&#8217;s competitor Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) does considerably better. You can find out more <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a>.
Photo courtesy: katz / Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/management/25/05/45456642/bill-ackman-loads-up-on-uber-dumps-nike-in-major-q1-portfolio-rebalance">Bill Ackman Loads Up On Uber In Major Q1 Portfolio Rebalance (CORRECTED)</a></li>
</ul>

Government

Health Care

Markets

Jim Cramer Reacts As UnitedHealth Denies  Report On Criminal Probe—'If Convicted of Criminal Medicare Fraud…'

The stock of Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) is trading higher on Thursday. But along with the rest of the healthcare sector, it is still in a steep downtrend. The news regarding <a href="https://www.benzinga.com/general/health-care/25/05/45443695/why-is-unitedhealth-stock-trading-lower-on-thursday">potential fraud at</a> UnitedHealth Group Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NASDAQ">UNH</a>) has put pressure on the entire sector.
But there is a good chance that Amgen finds a bottom soon. It may even reverse and head higher. This is why we have named it our Stock of the Day.
The shares are oversold.
The lower part of the chart is the Stochastics Momentum Indicator. If the blue line is below the lower horizontal red line, it indicates oversold conditions. As you can see, that is the case now.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-1024x560.png" alt="" class="wp-image-917099" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN.png 1488w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
This means that the shares have been aggressively sold and are trading below their typical or normal range. This could draw buyers into the market.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45435725/tariffs-slow-retail-spending-as-producer-prices-post-sharpest-drop-since-2020">Tariffs Slow Retail Spending As Producer Prices Post Sharpest Drop Since 2020</a>
Many trading strategies are based on the concept of reversion to the mean. This means buyers will be anticipating a reversal or move higher and their buying may become a self-fulfilling prophecy.
The shares are also getting close to a potential support level.
$255.50 was support in March 2023. It was also support in December 2024. Price levels that had previously been support can become so again because of trader and investor psychology.
Sometimes, people who sell shares while a stock is at a support level come to regret their decision to do so if the price rallies after. Many decide that if they eventually can, they will buy their shares back at the same price they sold them for.
As a result, if the stock eventually reverses and drops back to the support level, they place buy orders. If there are enough of them it will create support at the price again.
This is what happened with Amgen. If it continues to trend lower there is a good chance that it finds support at this important price again.
There is also a good chance that it rallies and reverses off of this level for a third time.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45436534/walmart-doesnt-alter-annual-outlook-yet-ceo-says-all-tariffs-create-cost-pressures-but-china-has-biggest-impact">Walmart Doesn&#8217;t Alter Annual Outlook Yet, CEO Says &#8216;All Tariffs Create Cost Pressures But China Has Biggest Impact&#8217;</a></li>
</ul>
Photo: Shutterstock

Technicals

Trading Ideas

AMGN

Stock Of The Day: Amgen Slips With Healthcare Sector, But Signals Point To A Reversal

U.S. stocks traded mixed Thursday, with major indices posting timid midday gains as investors digested fresh economic data revealing signs of consumer strain and disinflationary pressure stemming <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45435725/tariffs-slow-retail-spending-as-producer-prices-post-sharpest-drop-since-2020">from April's tariff escalation.</a>
Retail sales rose just 0.1% in April, slightly above flat expectations, but core retail sales—a category tied more closely to GDP—fell 0.3%, signaling weakening underlying consumption.
Producer prices contracted by 0.5% month-over-month, defying forecasts for an increase and marking the steepest drop since April 2020. 
Defensive sectors outperformed, with consumer staples and utilities leading gains, reflecting a cautious market tone.
In tech, semiconductor stocks—tracked by the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>)—edged down 0.4%, pulling back after a three-day rally sparked by the U.S.-China trade truce.
Oil prices slid 2.2%, with WTI light crude falling to $61 per barrel. Gold climbed 1.4% to above $3,200 per ounce, paring weekly losses amid renewed demand for inflation hedges.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was little changed, hovering around $103,436, continuing to trade in a narrow range since last Friday.
<h3 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Major Indices </td>
<td>Price</td>
<td>1-day %Chg</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,914.04</td>
<td>+0.3%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,202.33</td>
<td>+0.3%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,392.27</td>
<td>+0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,088.09</td>
<td>+0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:45 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul class="wp-block-list">
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.3% up to $589.95.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.4% to $422.17.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 0.5% to $471.29.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) rose 0.3% to $207.50.</li>
<li>The&nbsp;Utilities&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) outperformed, up 1.5%; the&nbsp;Energy&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.5%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers</h3>
<ul class="wp-block-list">
<li>UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) plunged more than 15% following reports that the Justice Department is conducting a criminal investigation into possible Medicare fraud involving the company. The company&#8217;s shares slump since April 15 has now extended to 56%, marking the worst 21-session drop in the company&#8217;s history.</li>
<li>Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) eased 0.5%, despite beating quarterly earnings estimates as the retail giant warned about higher prices later this month due to tariffs.</li>
<li>Cisco Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) soared nearly 6% after smashing earnings estimates in Q1. </li>
<li>Dicks Sporting Goods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) sunk 15% after announcing the acquisition of Foot Locker Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) for an equity value of $2.4 billion. Shares of Foot Locker Inc. skyrocketed 85%, recording their biggest one-day rise since the company went public in 1968. </li>
<li>Companies slated to report earnings after the close are Applied Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) and Take Two Interactive Software Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>)</li>
</ul>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/biotech/25/05/45438765/why-pfizer-is-poised-for-a-strong-comeback-my-top-pick-for-2025">Why Pfizer Is Poised For A Strong Comeback: My Top Pick For 2025 </a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Macro Economic Events

Regulations

Broad U.S. Equity ETFs

Econ #s

Economics

ETFs

$BTC

AMAT

CSCO

SPDR Dow Jones Industrial Average ETF Trust

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

TTWO

Select Sector SPDR-Consumer Discretionary

Wall Street Wavers As UNH Tumbles, Foot Locker Soars: What's Driving Markets Thursday?

U.S. stocks traded lower midway through trading, with the Dow Jones index gaining more than 150 points on Thursday.
The Dow traded up 0.40% to 42,218.43 while the NASDAQ rose 0.18% to 19,181.94. The S&amp;P 500 also rose, gaining, 0.43% to 5,917.84.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45435237/top-3-real-estate-stocks-youll-regret-missing-this-quarter">Top 3 Real Estate Stocks You&#8217;ll Regret Missing This Quarter</a>
Leading and Lagging Sectors Utilities shares jumped by 1.3% on Thursday.
In trading on Thursday, consumer discretionary stocks fell by 1.4%.
Top Headline
U.S. retail sales increased by 0.1% month-over-month in April compared to a revised 1.7% gain in March.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Click Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares shot up 168% to $0.7514 after the company announced it signed a cooperation agreement with Flash Mutual Technology.</li>
<li>Shares of Graphjet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) got a boost, surging 99% to $0.1916 after the company disclosed in 13D filing that its Co-Founder, CEO and CFO Aiden Lee Ping Wei reported A 48.9% stake in the company.</li>
<li>Foot Locker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) shares were also up, gaining 83% to $23.57 after DICK&#8217;s Sporting Goods agreed to acquire the company. Also, the company issued preliminary first-quarter non-GAAP EPS results.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares dropped 17% to $254.74 amid reports indicating the company is under investigation by the US Department of Justice for possible Medicare fraud. The company said it has not been notified by the Department of Justice of the supposed criminal investigation reported.</li>
<li>Shares of NanoVibronix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) were down 62% to $1.46 after the company announced the pricing of $10 million public offering of preferred stock and warrants.</li>
<li>REE Automotive Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REE#NASDAQ">REE</a>) was down, falling 71% to $0.9483 following fourth-quarter financial results. Additionally, the company announced it has temporarily paused production plans while monitoring ongoing manufacturing and supply chain conditions.</li>
</ul>
Commodities In commodity news, oil traded down 2.4% to $61.62 while gold traded up 0.6% at $3,208.00.
Silver traded down 0.1% to $32.40 on Thursday, while copper fell 0.1% to $4.6470.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.25%, while Spain's IBEX 35 Index rose 0.33%. London's FTSE 100 gained 0.23%, Germany's DAX 40 rose 0.29% and France's CAC 40 slipped 0.08% during the session.
Asia Pacific Markets
Asian markets closed mostly lower on Thursday, with Japan's Nikkei falling 0.98%, Hong Kong's Hang Seng Index declining 0.79%, China's Shanghai Composite Index falling 0.68% and India's BSE Sensex gaining 1.48%.
Economics
<ul class="wp-block-list">
<li>U.S. industrial production came in little changed in April, compared to market estimates of a 0.2% rise.</li>
<li>The Philadelphia Fed Manufacturing Index increased 22 points to a reading of –4.0 in May compared to a reading of -26.4 in April.</li>
<li>The NY Empire State Manufacturing Index declined to -9.2 in May compared to -8.1 in April, versus market estimates of -10.</li>
<li>Initial jobless claims came in unchanged from the previous week at 229,000 during the week ending May 10.</li>
<li>U.S. retail sales increased by 0.1% month-over-month in April compared to a revised 1.7% gain in March.</li>
<li>U.S. producer prices declined by 0.5% in April compared to a revised flat reading in the previous month and versus market estimates of a 0.2% gain.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45435278/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

CLIK

NAOV

Crude Oil Falls Over 2%; US Retail Sales Increase 0.1% In April

UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) stock is trading lower on Thursday in reaction to a media report on a possible investigation for <a target="_blank" href="https://www.benzinga.com/general/health-care/25/05/45426769/unitedhealth-stock-plunges-over-8-in-after-hours-trading-as-doj-criminal-probe-adds-to-turmoil-after-ceo-shake-up" rel="noreferrer noopener">criminal Medicare fraud</a>.
The Wall Street Journal <a href="https://www.wsj.com/us-news/unitedhealth-medicare-fraud-investigation-df80667f?tblci=GiCUX7wvU_AgmIIiQduNYr6JQuJQLy6SZJGvpyeZuCzyqiCN1VcoxvTN4f7-y-PqATDviEo">reported</a>, citing people familiar with the matter, that the healthcare-fraud unit of the Justice Department&#8217;s criminal division is overseeing the investigation, which has been active since at least last summer. 
UnitedHealth&#8217;s latest annual securities filing says the company &#8220;has been involved or is currently involved in various governmental investigations, audits and reviews,&#8221; and flags involved agencies including the Justice Department. 
It doesn&#8217;t specifically mention the criminal, civil and antitrust probes on which the Journal has reported.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44821140/unitedhealth-demands-rapid-repayment-of-cyberattack-relief-loan-billions-providers-say-push-undermines-recovery" rel="noreferrer noopener">UnitedHealth Demands Rapid Repayment Of Cyberattack Relief Loan Billions, Providers Say Push Undermines Recovery</a>
In a statement on Wednesday, the company <a target="_blank" href="https://www.unitedhealthgroup.com/newsroom/2025/2025-05-14-response-may-14-wsj-article.html" rel="noreferrer noopener">said</a>, &#8220;We have not been notified by the Department of Justice of the supposed criminal investigation reported, without official attribution, in the&nbsp;Wall Street Journal today.&#8221;
&#8220;We stand by the integrity of our Medicare Advantage program,&#8221; the company statement continued.
On Tuesday, UnitedHealth CEO Andrew Witty abruptly announced his resignation and suspended its <a href="https://www.benzinga.com/25/05/45373368/unitedhealth-stock-plunges-names-new-ceo-suspends-2025-guidance" target="_blank" rel="noreferrer noopener">fiscal year 2025 guidance</a>.
The insurance giant has garnered immense attention following the murder of its insurance unit CEO,&nbsp;Brian Thompson, in New York.
Luigi Mangione, the alleged perpetrator, pleaded not guilty to murder and weapons charges. Police found shell casings at the scene with the words &#8220;deny,&#8221; &#8220;defend,&#8221; and &#8220;depose,&#8221; commonly associated with insurance industry strategies for&nbsp;<a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/42771908/viral-tear-it-all-down-post-sparks-debate-over-unitedhealthcare-practices-alleges-denial-of-icu-care-for-comatose-patient" rel="noreferrer noopener">handling claims and disputes</a>.
According to a media report in February, the Justice Department reportedly launched a civil fraud investigation into&nbsp;UnitedHealth&#8217;s <a target="_blank" href="https://www.benzinga.com/25/02/43879859/doj-investigates-unitedhealth-probe-accuses-of-inflating-medicare-diagnoses" rel="noreferrer noopener">Medicare billing practices</a>.
The WSJ&nbsp;<a target="_blank" href="https://www.wsj.com/health/healthcare/unitedhealth-medicare-doj-diagnosis-investigation-66b9f1db?mod=latest_headlines&amp;tblci=GiCUX7wvU_AgmIIiQduNYr6JQuJQLy6SZJGvpyeZuCzyqiCN1VcoxvTN4f7-y-PqATDviEo" rel="noreferrer noopener">reported</a>&nbsp;that Medicare paid substantial sums to UnitedHealth based on diagnoses added to patients&#8217; records, some of which doctors said were irrelevant or undocumented.
In March, a Special Master recommended granting&nbsp;UnitedHealth&#8217;s&nbsp;motion for summary judgment in a False Claims Act (FCA) case, concluding that the government lacks evidence&nbsp;<a target="_blank" href="https://www.benzinga.com/25/03/44141489/false-claims-act-case-against-unitedhealth-faces-dismissal-recommendation" rel="noreferrer noopener">to support its allegations</a>.
In April, UnitedHealth got some relief when the Federal Trade Commission (FTC) paused the formal complaint against three major pharmacy benefit managers (PBMs) for allegedly engaging in unfair and anti-competitive practices that have inflated the list&nbsp;<a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44627279/ftc-pauses-lawsuit-against-cvs-cigna-unitedhealths-pbms-amid-commissioner-shortage" rel="noreferrer noopener">price of insulin medications</a>.
Analyst Reaction:
<ul class="wp-block-list">
<li>Keybanc maintains UnitedHealth with an Overweight rating, lowering the <a href="https://www.benzinga.com/quote/UNH/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $575 to $450</a>.</li>
<li>Baird maintains UnitedHealth with an Outperform rating, lowering the price target from $510 to $356.</li>
<li>BofA Securities downgrades UnitedHealth from Buy to Neutral and lowers the price target from $560 to $350.</li>
<li>Morgan Stanley maintains UnitedHealth with an Overweight rating, lowering the price target from $563 to $374.</li>
<li>Wells Fargo maintains UnitedHealth with an Overweight, lowering the price target from $677 to $351.</li>
<li>Oppenheimer maintains UnitedHealth with an Outperform rating, lowering the price target from $600 to $400.</li>
<li>Deutsche Bank maintains UnitedHealth with a Buy, lowering the price target from $521 to $362.</li>
<li>JP Morgan maintains UnitedHealth with an Overweight, lowering the price target from $525 to $405.</li>
</ul>
Price Action: UnitedHealth stock is down 7.83% at $283.88 during the premarket session at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45435748/dicks-sporting-goods-to-acquire-foot-locker-at-66-premium" target="_blank" rel="noreferrer noopener">Dick&#8217;s Sporting Goods To Acquire Foot Locker At 66% Premium</a></li>
</ul>
Image: Shutterstock

Large Cap

Legal

Movers

General

Why Is UnitedHealth Stock Trading Lower On Thursday?

An official report on May 14, 2025 reveals Senator John Boozman's recent purchase of UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) stock, valued between $9,009 and $135,000. The transaction took place on May 14, 2025, as per the May filing.
At this time, UnitedHealth Group shares are trading down 18.51% at $251.0.
<h3>What Senator Has Been Trading Recently</h3>
In the past three years, John Boozman made 132 stock trades totaling more than $258 thousand. The largest trades involved stocks like iShares MSCI EAFE ETF and iShares MSCI EAFE Small-Cap ETF. Their most notable trades made recently include key transactions: 
<ul>
<li>Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>): $1,001 - $15,000 Purchase</li>
<li>Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>): $1,001 - $15,000 Purchase</li>
<li>Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>): $1,001 - $15,000 Purchase</li>
</ul>
Here's a summary of John Boozman's recent trades:
<table>
<thead>
<tr>
<th>Company</th>
<th>Ticker</th>
<th>Stock Type</th>
<th>Amount</th>
<th>Transaction Type</th>
<th>Transaction Date</th>
</tr>
</thead>
<tbody>
<tr>
<td>Salesforce</td>
<td>CRM</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S (Partial)</td>
<td>2025-04-22</td>
</tr>
<tr>
<td>Microsoft</td>
<td>MSFT</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>P</td>
<td>2025-04-22</td>
</tr>
<tr>
<td>Lam Research</td>
<td>LRCX</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S (Partial)</td>
<td>2025-04-16</td>
</tr>
<tr>
<td>Gilead Sciences</td>
<td>GILD</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S</td>
<td>2025-04-16</td>
</tr>
<tr>
<td>Applied Mat</td>
<td>AMAT</td>
<td>STOCK</td>
<td>$1,001 - $15,000</td>
<td>S (Partial)</td>
<td>2025-04-16</td>
</tr>
</tbody>
</table>
To stay updated on John Boozman's trades and other congressional trades, try our <a href="https://www.benzinga.com/gov-trades/members/john-boozman">government trades tool</a> for live updates!
<h3>The Importance of Congressional Transactions</h3>
A congressional transaction is when any representative or senator either buys or sells an individual stock.
Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.
In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.
<h3>Why Congressional Transactions Matter</h3>
Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.
When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.
A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Politics

LRCX

MSFT

Recent Filing Shows That Sen. John Boozman Bought Over $9K Worth of UnitedHealth Group Stock

In a market where healthcare stocks are facing their worst month in 24 years, Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) is <a href="https://www.benzinga.com/quote/PLTR/news">stealing the spotlight</a>, soaring over 32% in the past month and a staggering 500% over the past year.
Meanwhile, UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), the healthcare giant, has been hammered—down over 40% over the past year and 47% in the last month alone, dragged by a suspended 2025 outlook and <a href="https://www.benzinga.com/25/05/45373368/unitedhealth-stock-plunges-names-new-ceo-suspends-2025-guidance">CEO Andrew Witty's unexpected departure</a>.
<h2 class="wp-block-heading">Palantir's AI-Powered Rocket Ride</h2>
Palantir's free cash flow last year hit <a href="https://x.com/thexcapitalist/status/1922759443835420724">$1.3 billion</a>, backing a $300 billion market cap that investors are rewarding amid the AI revolution. 
The company's cutting-edge analytics software has secured growing contracts from both government and commercial clients, fueling revenue growth of 50% over the past two years. 
Riding the tech wave, clocking gains of over 32% over the past month alone, Palantir stock has outperformed the broader S&amp;P 500-tracking SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and tech-heavy Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>), which gained 9% and 17%, respectively.
Read Also: <a href="https://www.benzinga.com/etfs/sector-etfs/25/05/45428416/cathie-wood-tesla-palantir-coinbase-shopify-are-tip-of-the-spear-as-innovation-leaves-indexes-scrambling">Cathie Wood Says Palantir, Tesla, Coinbase And This Amazon Rival Are &#8216;Tip Of The Spear&#8217; As Innovation Disrupts Old World In Equity Benchmarks</a>
<h2 class="wp-block-heading">UnitedHealth's Rocky Road</h2>
By contrast, UnitedHealth's free cash flow dwarfs Palantir's at $25 billion, but its $285 billion market cap reflects investor concerns. 
Regulatory pressures, rising costs, and antitrust scrutiny have spooked shareholders, dragging down the entire Health Care Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>). In a month when the S&amp;P 500 climbed 9%, the fund dropped 7%.
UnitedHealth's troubles underline the broader healthcare sector's struggles, lagging the market by the largest margin in over two decades.
The story here is clear. While healthcare faces mounting headwinds, AI-driven tech stocks like Palantir are powering ahead, rewriting the rules of growth and value in 2025's stock market.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/health-care/25/05/45424904/unitedhealth-stock-caught-in-a-perfect-storm-falls-nearly-50-since-april">UnitedHealth Stock Caught In A Perfect Storm, Falls Nearly 50% Since April</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Tech

PLTR

Palantir Soars 500% In A Year While UnitedHealth Tanks 40% — Tech Leaves Healthcare In The Dust

WIIM

UnitedHealth shares are trading lower amid reports indicating the company is under investigation by the US Department of Justice for possible Medicare fraud. The company said it has not been notified by the Department of Justice of the supposed criminal investigation reported.

<ul>
<li>UNH</li>
<li>WMT</li>
<li>TSLA</li>
<li>NVDA</li>
<li>GLD</li>
<li>BABA</li>
<li>GOOGL</li>
<li>BULL</li>
<li>AAPL</li>
<li>PLTR</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

BABA

BULL

GOOGL

NVDA

TSLA

Top 10 Trending Stocks On WallStreetBets As Of May 15, 2025 (Via Swaggy Stocks)

Barclays analyst Andrew Mok maintains UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Overweight and lowers the price target from $513 to $362.

Price Target

Analyst Ratings

Barclays Maintains Overweight on UnitedHealth Group, Lowers Price Target to $362

U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday.
Shares of Red Cat Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected <a href="https://in.benzinga.com/news/earnings/25/05/45421747/red-cat-holdings-q1-earnings-revenue-eps-miss-estimates-drone-maker-affirms-fy25-guidance-highlights-palantir-partnership-shares-slide">quarterly financial results</a>.
Red Cat reported first-quarter revenue of $1.63 million, missing analyst estimates of $3.85 million. The company reported a first-quarter loss of 27 cents per share, missing analyst estimates for a loss of eight cents per share, according to Benzinga Pro.
Red Cat shares tumbled 13.4% to $5.76 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>New Fortress Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NYSE">NFE</a>) fell 31.3% to $4.66 in today's pre-market trading after the company reported a first-quarter sales miss.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) shares tumbled 19.8% to $4.90 in pre-market trading.</li>
<li>DXC Technology Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>) declined 15.8% to $13.95 in pre-market trading after the company reported fourth-quarter financial results and issued first-quarter guidance below estimates. Also, the company issued FY26 adjusted EPS guidance below estimates.</li>
<li>Ruanyun Edai Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) shares declined 15.7% to $8.07 in pre-market trading.</li>
<li>Biohaven Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHVN#NYSE">BHVN</a>) shares tumbled 12.3% to $17.24 in pre-market trading. The FDA extended PDUFA date of Biohaven&#8217;s Troriluzole NDA for rare disease Spinocerebellar Ataxia.</li>
<li>DICK&#8217;S Sporting Goods, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) fell 8% to $192.80 in pre-market trading after the company reported select preliminary financial results for its first quarter.</li>
<li>UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) declined 6.1% to $289.25 in pre-market trading.</li>
<li>Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) fell 5.8% to $126.24 in pre-market trading after the company reported downbeat quarterly revenue.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45405004/jim-cramer-sofi-goes-to-new-highs-recommends-not-buying-this-health-care-stock">Jim Cramer: SoFi Goes To &#8216;New Highs,&#8217; Recommends Not Buying This Health Care Stock</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

BHVN

RCAT

RYET

SHLS

Red Cat Holdings, Alibaba, DXC Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

JP Morgan analyst Lisa Gill maintains UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Overweight and lowers the price target from $525 to $405.

JP Morgan Maintains Overweight on UnitedHealth Group, Lowers Price Target to $405

<a href="https://www.unitedhealthgroup.com/newsroom/2025/2025-05-14-response-may-14-wsj-article.html" title="https://www.unitedhealthgroup.com/newsroom/2025/2025-05-14-response-may-14-wsj-article.html">https://www.unitedhealthgroup.com/newsroom/2025/2025-05-14-response-may-14-wsj-article.html</a>

UnitedHealth, In Response To WSJ Article, Says 'We have not been notified by the Department of Justice of the supposed criminal investigation reported'

UNH: -7% &#x7C; <a href="https://www.benzinga.com//node/45432651">UnitedHealth shares are trading lower amid reports indicating the company is under investigation by the US Department of Justice for possible Medicare fraud.</a>
&nbsp;
CRWV: -9% &#x7C; <a href="https://www.benzinga.com//node/45419772">CoreWeave Q1 GAAP EPS $(1.49), Sales $981.63M Beat $859.77M Estimate</a>
&nbsp;
WMT: 3% &#x7C; <a href="https://www.benzinga.com//node/45432616">Walmart shares are trading higher following Q1 financial results.</a>

CRWV

Market-Moving News for May 15th

U.S. stock futures were lower on Thursday after mostly closing higher on Wednesday. Futures of major benchmark indices were trading lower in premarket.
Wednesday saw a positive momentum in tech stocks led by Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) following the <a href="https://www.benzinga.com/news/large-cap/25/05/45405067/saudi-arabia-bets-big-on-ai-teams-up-with-aws-and-nvidia">deals with Saudi Arabia</a>, strong earnings from Cisco Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) and CoreWeave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>). 
Nvidia CEO Jensen Huang, who last year sparked &#8220;Jensanity&#8221; among attendees, will headline this year&#8217;s <a href="https://www.benzinga.com/media/25/05/45426637/nvidia-ceo-jensen-huang-expected-to-unveil-new-ai-alliances-at-computex-2025-as-geopolitical-pressures-persist-over-tech-sector">annual Computex trade show</a>, which will run from May 20–23 in Taipei, reported Reuters. His keynote is expected to spotlight Nvidia&#8217;s deepening partnerships with Taiwanese firms like Foxconn and Quanta. 
Investors assessed the economic impacts of a tariff pause with China and await the Producer Price Index data slated to be released today.
The 10-year Treasury bond yielded 4.50% and the two-year bond was at 4.03%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool&#8217;</a>s projections show markets pricing a 91.7% likelihood of the Federal Reserve keeping the current interest rates unchanged in its June meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.42%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.81%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.63%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.35%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell in premarket on Thursday. The SPY was down 0.68% to $583.57, while the QQQ declined 0.87% to $514.18, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Driven by renewed risk appetite after U.S.-China trade negotiation progress, information technology and communication services sectors led gains on Wednesday, bucking the broader negative trend where health care, materials, and real estate stocks saw the biggest losses.
Overall, U.S. stocks settled mixed, with the S&amp;P 500 extending its gains for a third session, up over 4% week-to-date, while the Dow added around 2% and the Nasdaq surged over 6% for the week.
Notably, Nvidia and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) shares climbed significantly. Separately, U.S. mortgage applications saw a modest increase of 1.1%.
The Dow Jones index declined 89 points or 0.21% to 42,051.06, whereas the S&amp;P 500 index rose 0.10% to 5,892.58. Nasdaq Composite ended 0.72% higher at 19,146.81, and the small-cap gauge, Russell 2000, dropped 0.88% to 2,083.80.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.72%</td>
<td>19,146.81</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.10%</td>
<td>5,892.58</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.21%</td>
<td>42,051.06</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>0.88%</td>
<td>2,083.80</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
According to Scott Wren, the senior global market strategist at Wells Fargo, despite having a bit of a surprise in the outcome in terms of the U.S.-China trade talks, &#8220;The bottom line is that many uncertainties remain.&#8221;
&#8220;The U.S. is in the early stages of trade negotiations. Given that, our guidance is to continue to lean toward higher-quality large- and mid-cap U.S. equities. In fixed income, we favor exposure to investment-grade corporates and essential-service municipal bonds in the three-to-seven-year maturity range,&#8221; he said.
He highlighted that the market bounce back hinged on a variety of factors, including better-than-expected earnings and, particularly, guidance during the first-quarter reporting season as well as expectations that some trade deals would be announced (i.e., last week's U.K. deal).
It also has helped that much of the reported data covering April has so far continued to show U.S. economic resilience, he explained.
Talking about the U.S.-China deal, he said, &#8220;Of course, as always, the devil is in the details, and a deal has not officially been inked. A lot can happen between now and then.&#8221;
Meanwhile, the analysts at BlackRock said that &#8220;We eye opportunities from mega forces,&#8221; adding that &#8220;We still see tariffs causing further contractions in quarterly activity but the cumulative impact may be more limited.&#8221;
&#8220;We still see supply disruptions upping inflation and hitting growth, but also a path to avoiding a U.S. contraction over 2025 as a whole. Mega forces, greater fiscal spending, and higher interest rates are driving select opportunities,&#8221; the note added.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a> 
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Thursday:
<ul class="wp-block-list">
<li>The initial jobless claims data for the week ended May 10 will be out by 8:30 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>April&#8217;s U.S. retail sales, core and headline producer price index, May&#8217;s Empire State manufacturing survey, and Philadelphia Fed manufacturing survey will also be announced at 8:30 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>Fed Chairman Jerome Powell will speak at 8:40 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>April&#8217;s industrial production and capacity utilization will be out by 9:15 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>March&#8217;s business inventories data and May&#8217;s home builder confidence index will be released by 10:00 a.m. ET.</li>
</ul>
<ul class="wp-block-list">
<li>Fed Governor Michael Barr will speak at 2:05 p.m. ET.</li>
<li></li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>Alibaba Group Holding Ltd. ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) fell 1.12% as analysts expect it to report quarterly earnings of $1.37 per share on revenue of $33.21 billion, before the opening bell.</li>
</ul>
<ul class="wp-block-list">
<li>Deere &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>) was down 0.24% as Wall Street expects it to report earnings before the opening bell. It is expected to post earnings of $5.58 per share on revenue of $10.79 billion.</li>
</ul>
<ul class="wp-block-list">
<li>Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) was 0.43% higher as analysts expect it to report quarterly earnings of 58 cents per share on revenue of $165.88 billion, before the opening bell.</li>
</ul>
<ul class="wp-block-list">
<li>Boot Barn Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) jumped 14.51% despite posting downbeat earnings for its fourth quarter, but issued first-quarter guidance with its midpoint above estimates. The company also announced a $200 million share repurchase program.</li>
</ul>
<ul class="wp-block-list">
<li>Cisco Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) advanced 3.44% after posting stronger-than-expected results for its third quarter and raising its fiscal 2025 guidance.</li>
</ul>
<ul class="wp-block-list">
<li>Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) was up 0.97% after it inked a record-breaking deal with Qatar Airways of up to 210 planes.</li>
</ul>
<ul class="wp-block-list">
<li>UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) declined 4.87% after a report that the Justice Department is investigating the company for possible Medicare fraud.</li>
</ul>
<ul class="wp-block-list">
<li>Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) was 0.93% lower after announcing the redemption of &#8216;series G&#8217; preferred stock.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 3.99% to hover around $60.63 per barrel.
Gold Spot US Dollar fell 0.43% to hover around $3,164.60 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was lower by 0.31% at the 100.7260 level.
Asian markets ended lower on Thursday except India's S&amp;P BSE Sensex and Australia's ASX 200 index. Japan's Nikkei 225, Hong Kong's Hang Seng, South Korea's Kospi, and China&#8217;s CSI 300 indices declined. European markets were mostly lower in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/market-summary/25/05/45399940/warren-buffett-shows-how-patience-pays-98-of-his-160-billion-wealth-came-after-turning-65-thanks-the-power-of-compound-interest">Warren Buffett Shows How Patience Pays: 98% Of His $160 Billion Wealth Came After Turning 65, Thanks The Power Of &#8216;Compound Interest&#8217;</a></li>
</ul>
Image Via Shutterstock

Analyst Color

Asia

Earnings Beats

Earnings Misses

Macro Notification

Market Summary

Bonds

Guidance

Emerging Markets

Futures

Forex

Treasuries

Federal Reserve

BOOT

SCHW

US Stocks Likely To Open Lower After S&P 500's Three-Day Winning Streak: '...Many Uncertainties Remain,' Says Expert

U.S. stock markets saw a positive shift on Wednesday, with the S&amp;P 500 and Nasdaq 100 indices turning green for the year. The market&#8217;s upbeat sentiment was buoyed by a favorable inflation report and easing trade tensions, particularly benefiting the tech sector.
The S&amp;P 500 rose 0.1% to 5,892.58 for the day, while the Nasdaq gained 0.7% to 19,146.81. The Dow Jones Industrial Average ended Wednesday lower by 0.2% at 42,051.06.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
UnitedHealth Group Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)
UnitedHealth shares dipped 1.08% to close at $308.01, hitting an intraday high of $322.94 and a low of $307.11. The stock&#8217;s 52-week range is $307.11 to $630.73. The decline comes amid a <a href="https://www.benzinga.com/general/health-care/25/05/45426769/unitedhealth-stock-plunges-over-8-in-after-hours-trading-as-doj-criminal-probe-adds-to-turmoi">criminal investigation</a> by the U.S. Department of Justice into potential Medicare fraud, adding to the turmoil following the sudden exit of its CEO. In after-hours trading, UnitedHealth shares fell over 8% to $283.13.
Alibaba Group Holding Ltd.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)
Alibaba&#8217;s stock rose 1.82% to $134.05, with a daily high of $134.51 and a low of $132.65. The 52-week high and low are $148.43 and $71.80, respectively. The stock&#8217;s upward momentum is fueled by <a href="https://www.benzinga.com/trading-ideas/technicals/25/05/45405917/alibabas-55-rally-gets-goldmans-1-billion-boost-will-q4-earnings-justify-the-bet">investor optimism</a> around its AI-driven transformation and a significant endorsement from Goldman Sachs, ahead of its upcoming earnings report.
See Also:&nbsp;<a href="https://benzinga.com/markets/equities/25/05/45398595/trump-praises-nvidia-ceo-jensen-huang-at-saudi-summit-tim-cook-isnt-here-but-you-are-controlling" target="_blank" rel="noreferrer noopener">Trump Praises Nvidia CEO Jensen Huang At Saudi Summit: &#8216;Tim Cook Isn&#8217;t Here, But You Are&#8217; Controlling 99% Of The Chip Market: &#8216;That&#8217;s Not Easy To Beat&#8217;</a>
Reddit Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>)
Reddit shares surged 11.06% to $125.32, reaching an intraday high of $130.11 and a low of $113.80. The stock&#8217;s 52-week range is $49.13 to $230.41. The rally follows <a href="https://www.benzinga.com/news/25/05/45418498/reddit-rddt-stock-is-up-25-over-the-past-month-whats-going-on">strong first-quarter earnings</a> that exceeded expectations, showcasing increased revenue, profitability, and user growth.
Rocket Lab USA Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>)
Rocket Lab&#8217;s stock climbed 10.54% to $24.13, with a high of $24.52 and a low of $21.86. The 52-week high and low are $33.34 and $4.15. The company&#8217;s shares rose following the successful return of its Pioneer spacecraft, marking its second Earth return mission in two months. Reddit posted earnings of 13 cents per share, beating the consensus estimate of 2 cents.
Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla shares increased by 4.07% to $347.68, with an intraday high of $350 and a low of $337. The stock&#8217;s 52-week range is $157.4 to $488.54. The rise is attributed to&nbsp;<a href="https://www.benzinga.com/trading-ideas/movers/25/05/45417105/tesla-stock-continues-to-climb-whats-going-on">easing trade tensions</a>&nbsp;between the U.S. and China, alongside renewed investor confidence in Tesla&#8217;s robotaxi rollout and next-gen vehicle production.
Benzinga Edge Stock Rankings shows Alibaba has Momentum in the 95th percentile and Growth in the 73rd percentile, but how does rival JD.com rank up against the Jack Ma-founded e-commerce giant in terms of Quality and Value? <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Find out here</a>.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="446" height="281" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14225032/Screenshot-2025-05-15-at-11.49.52.png" alt="" class="wp-image-915873" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14225032/Screenshot-2025-05-15-at-11.49.52.png 446w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14225032/Screenshot-2025-05-15-at-11.49.52-300x189.png 300w" sizes="(max-width: 446px) 100vw, 446px" /></a></figure>
Photo Courtesy: Phongphan On Shutterstock.com
Prepare for the day&#8217;s trading&nbsp;<a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a>&nbsp;by Benzinga.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45426626/cathie-woods-wednesday-wisdom-bets-on-airbnbs-platform-expansion-dumps-palantir-at-peak">Cathie Wood&#8217;s Wednesday Wisdom? Bets On Airbnb&#8217;s Platform Expansion, Dumps Palantir At Peak</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

RDDT

RKLB

Reddit, Rocket Lab, Tesla, Alibaba, And Unitedhealth: Why These 5 Stocks Are On Investors' Radars Today

The crisis at UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) continues to deepen, with a new criminal investigation by federal authorities, following the abrupt departure of its CEO, and a steep decline in stock prices.
What Happened: UnitedHealth is reportedly under criminal investigation by the U.S. Department of Justice for possible Medicare fraud, according to a Wall Street Journal <a href="https://www.wsj.com/us-news/unitedhealth-medicare-fraud-investigation-df80667f">report</a>, which cited people familiar with the matter.
The probe, overseen by the DOJ&#8217;s criminal healthcare fraud division, has reportedly been active since at least last summer and is focused on UnitedHealth's Medicare Advantage business practices. It marks the latest in a string of challenges facing the health insurance giant in recent months.
This comes just a day after the <a href="https://www.benzinga.com/25/05/45373368/unitedhealth-stock-plunges-names-new-ceo-suspends-2025-guidance">sudden exit of CEO</a> Andrew Witty, who has since been replaced by the company&#8217;s Chairman and former CEO, Stephen Hemsley. 
While the DOJ has struggled to secure convictions in past Medicare fraud claims against UnitedHealth, the criminal nature of the current probe raises the stakes significantly as the company contends with mounting regulatory scrutiny and a declining stock price.
The company, however, has since responded to Benzinga in a press release stating that it has not been notified of any supposed criminal investigation by the DOJ. It further adds that WSJ&#8217;s reporting is deeply irresponsible, and that the company stands by the integrity of its Medicare Advantage program.
See Also: <a href="https://www.benzinga.com/25/05/45425598/elon-musks-dad-says-its-wonderful-he-has-14-kids-and-doesnt-need-to-follow-so-called-morals-hes-not-married-h">Elon Musk&#8217;s Dad Says It&#8217;s &#8216;Wonderful&#8217; He Has 14 Kids And Doesn&#8217;t Need To Follow &#8216;So-Called Morals&#8217; —&#8217;He&#8217;s Not Married, He Can Do Whatever He Likes&#8217;</a>
Why It Matters: The company has been <a href="https://benzinga.com/general/health-care/25/05/45424904/unitedhealth-stock-caught-in-a-perfect-storm-falls-nearly-50-since-april">caught in a perfect storm</a> in recent months, with the stock down nearly 50% since April, owing to a string of negative catalysts. 
UnitedHealth decided to <a href="https://www.benzinga.com/25/05/45373368/unitedhealth-stock-plunges-names-new-ceo-suspends-2025-guidance">suspend its outlook</a> for 2025 early this week, citing the continuing acceleration in care activity, adding to the stock&#8217;s woes. 
This comes amid a <a href="https://www.benzinga.com/general/health-care/25/05/45305392/unitedhealth-investors-claim-company-hid-profit-impact-of-ceos-murder">fresh shareholder lawsuit</a>, which claims that the company hid the potential impact of its former CEO, Brian Thompson&#8217;s murder in December 2024, and the resulting backlash and regulatory scrutiny.
In February, investor Bill Ackman said in a post on X that when a company attacks its critics, the probability of it having committed fraud or being guilty of a crime &#8220;increases substantially.&#8221; 
&#8220;When you find two cockroaches, it is almost a certainty that there are many more. And a half a trillion market cap for a health insurer makes no sense,&#8221; he said. 
<figure class="wp-block-embed aligncenter is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">When a company, in this case United Healthcare, attacks its critics, the probability that it has committed fraud or is guilty of a crime increases substantially. This morning the DOJ announced an investigation into UNH's Medicare billing practices. The DOJ did not do this… <a href="https://t.co/BX3WtYzRJi">https://t.co/BX3WtYzRJi</a>
&mdash; Bill Ackman (@BillAckman) <a href="https://twitter.com/BillAckman/status/1892912458840547554?ref_src=twsrc%5Etfw">February 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Price Action: The stock was down 1.08% on Wednesday, trading at $308.01, and is down 8.08% after hours after news of the criminal investigation was made public. 
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="138" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14215541/Screenshot-2025-05-15-at-7.24.44-AM-1024x138.png" alt="" class="wp-image-915844" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14215541/Screenshot-2025-05-15-at-7.24.44-AM-1024x138.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14215541/Screenshot-2025-05-15-at-7.24.44-AM-300x40.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14215541/Screenshot-2025-05-15-at-7.24.44-AM-768x103.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14215541/Screenshot-2025-05-15-at-7.24.44-AM-1536x206.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14215541/Screenshot-2025-05-15-at-7.24.44-AM.png 1592w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
According to Benzinga&#8217;s Edge Stock Rankings, UnitedHealth stock is placed in the 11th percentile on Momentum. How does it compare with peers such as Aetna Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AET#NYSE">AET</a>)? <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Find out more</a>. 
Photo: JHVEPhoto / Shutterstock
Read More: <a href="https://www.benzinga.com/government/regulations/25/05/45419575/capital-one-sued-by-new-york-over-hidden-interest-rate-scheme-that-cost-consumers-millions">Capital One Sued By New York Over Hidden Interest Rate Scheme That Cost Consumers Millions</a>

UnitedHealth Stock Plunges Over 8% In After-Hours Trading As DOJ Criminal Probe Adds To Turmoil After CEO Shake-Up

UnitedHealth Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) has fallen nearly 50% over the past month, fueled by a series of <a href="https://www.benzinga.com/25/05/45388424/stock-of-the-day-where-will-the-unitedhealth-meltdown-end">negative catalysts. </a>
Several analysts have slashed price targets on the stock, but one analyst has seen enough and downgraded UnitedHealth on Wednesday.&nbsp;
What To Know: BofA Securities analyst Kevin Fischbeck downgraded UnitedHealth Group from Buy to Neutral and slashed the price target from $560 to $350 after the company pulled its 2025 outlook and announced a CEO transition on Tuesday. 
Read Next: <a href="https://www.benzinga.com/general/health-care/25/05/45384935/trump-again-promises-lower-drug-prices-by-cutting-out-middlemen-like-unitedhealth-cvs-will-it-work-this-time?utm_source=articleShare">Trump Again Promises Lower Drug Prices By &#8216;Cutting Out Middlemen&#8217; Like UnitedHealth, CVS: Will It Work This Time?</a>
UnitedHealth pulled<a href="https://www.benzinga.com/25/05/45373368/unitedhealth-stock-plunges-names-new-ceo-suspends-2025-guidance"> its guidance</a> after the company noticed its Medicare Advantage trend worsening and spreading to more complex patients, like dual enrollments. The analyst said the worsening trend became clear after UnitedHealth completed its March claims and had an early look at April's claims. 
Fischbeck views the health care giant&#8217;s decision to pull its fiscal guidance as a combination of uncertainty around the prevalence of higher utilization rates and to allow time for the incoming CEO to adjust.&nbsp;
Andrew Witty unexpectedly <a href="https://www.benzinga.com/pressreleases/25/05/b45370370/unitedhealth-group-announces-leadership-transition">resigned </a>as CEO "due to personal reasons" on Tuesday and will be succeeded by Stephen J. Hemsley, who served as UnitedHealth's CEO from 2006 to 2017. 
What Else: UnitedHealth shareholders<a href="https://www.benzinga.com/general/health-care/25/05/45305392/unitedhealth-investors-claim-company-hid-profit-impact-of-ceos-murder"> filed a lawsuit</a> last week that alleges the company misled investors by concealing the negative business impacts that followed the December 2024 killing of UnitedHealthcare <a href="https://www.benzinga.com/news/legal/25/02/43887520/luigi-mangione-back-in-court-friday-supporters-donate-500k-to-suspected-killer">CEO Brian Thompson.</a>
The company is still reeling from a major cyberattack on its Change Healthcare subsidiary and also faces intense regulatory and legal scrutiny, including federal investigations into its Medicare billing practices.
The recent convergence of disappointing earnings, surging medical costs, pulled forward guidance, abrupt leadership change and regulatory challenges have undermined investor confidence and triggered a dramatic revaluation of UnitedHealth stock over the past month.&nbsp;
UNH Stock Price Action: UnitedHealth Group shares ended Wednesday's session down 1.08% at $308.01, according to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>. 
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/health-care/25/05/45305392/unitedhealth-investors-claim-company-hid-profit-impact-of-ceos-murder">UnitedHealth Investors Claim Company Hid Profit Impact Of CEO&#8217;s Murder</a></li>
</ul>
Photo: Shutterstock

Downgrades

Insurance

UnitedHealth Stock Caught In A Perfect Storm, Falls Nearly 50% Since April

Deutsche Bank analyst George Hill maintains UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) with a Buy and lowers the price target from $521 to $362.

Deutsche Bank Maintains Buy on UnitedHealth Group, Lowers Price Target to $362

Live On CNBC, Steve Weiss Announces Bought More UnitedHealth Group

Press Releases

UNH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that UnitedHealth Group Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

UnitedHealth Group Announces Leadership Transition

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines - UNH

UNH BREAKING NEWS: UnitedHealth Group Incorporated Replaces CEO and Suspends Guidance – Contact BFA Law about the Class Action if You Lost Money (NYSE:UNH)

UNH LEGAL NEWS: UnitedHealth Group Incorporated Stock Plummets 22% Triggering Class Action – Investors are Notified to Contact BFA Law by July 7 (NYSE:UNH)

UNH Investors Have Opportunity to Lead UnitedHealth Group Incorporated Securities Fraud Lawsuit First Filed by the Firm

UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

Ademi & Fruchter LLP Continues to Investigate Claims of Securities Fraud against UnitedHealth Group Incorporated

UnitedHealth Group (UNH) Shares Sharply Down Again After CEO Resignation, 2025 Guidance Suspension; Securities Class Action Pending – Hagens Berman

UNH CLASS ACTION: A Securities Fraud Lawsuit was filed on behalf of UnitedHealth Group Incorporated Investors -- Contact BFA Law by July 7 Deadline (NYSE:UNH)

Comments

UnitedHealth Group

Intérêt court

UnitedHealth Group (NYSE:UNH) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL